Canada Markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
164.61-0.93 (-0.56%)
At close: 04:00PM EST
164.47 -0.14 (-0.09%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close165.54
Open166.03
Bid0.00 x 900
Ask0.00 x 1200
Day's Range163.89 - 166.34
52 Week Range155.72 - 186.69
Volume6,841,561
Avg. Volume7,077,178
Market Cap430.37B
Beta (5Y Monthly)0.56
PE Ratio (TTM)29.08
EPS (TTM)5.66
Earnings DateApr 17, 2023 - Apr 21, 2023
Forward Dividend & Yield4.52 (2.62%)
Ex-Dividend DateNov 21, 2022
1y Target Est183.80
  • Motley Fool

    3 Dow Stocks That Make for Screaming Buys in February

    Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.

  • Yahoo Finance

    COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst

    Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.

  • Reuters

    COLUMN-3M foes act fast to capitalize on J&J’s talc bankruptcy defeat

    When a U.S. appeals court ruled on Monday that Johnson & Johnson can’t use the U.S. bankruptcy system to offload vast litigation exposure from product liability claims, the people who reacted most quickly were undoubtedly J&J investors. Within hours of the 3rd U.S. Circuit Court of Appeals decision, investors drove J&J’s share price down by nearly 4% -- its biggest one-day decline in years. But another, albeit much smaller, group of people was also roiled by Monday’s ruling from the 3rd Circuit: appellate lawyers who were finishing up friend-of-the-court briefs due on Wednesday in a 7th Circuit appeal by 3M Co that presents issues similar to those in the J&J case.